GB201720622D0 - Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary - Google Patents

Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary

Info

Publication number
GB201720622D0
GB201720622D0 GBGB1720622.8A GB201720622A GB201720622D0 GB 201720622 D0 GB201720622 D0 GB 201720622D0 GB 201720622 A GB201720622 A GB 201720622A GB 201720622 D0 GB201720622 D0 GB 201720622D0
Authority
GB
United Kingdom
Prior art keywords
cyanobenzoyl
methylbenzamide
pyrazol
cyclopropyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1720622.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mereo Biopharma 3 Ltd
Original Assignee
Mereo Biopharma 3 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 3 Ltd filed Critical Mereo Biopharma 3 Ltd
Priority to GBGB1720622.8A priority Critical patent/GB201720622D0/en
Publication of GB201720622D0 publication Critical patent/GB201720622D0/en
Priority to US15/733,213 priority patent/US11234967B2/en
Priority to EP18819365.0A priority patent/EP3585382B1/en
Priority to JP2020531614A priority patent/JP7372680B2/en
Priority to DK18819365.0T priority patent/DK3585382T3/en
Priority to ES18819366T priority patent/ES2882978T3/en
Priority to KR1020207019715A priority patent/KR20200097311A/en
Priority to EP18819366.8A priority patent/EP3585383B1/en
Priority to PL18819366T priority patent/PL3585383T3/en
Priority to CA3085544A priority patent/CA3085544A1/en
Priority to HUE18819366A priority patent/HUE054266T2/en
Priority to PT188193650T priority patent/PT3585382T/en
Priority to EP21156673.2A priority patent/EP3845228A1/en
Priority to PCT/GB2018/053591 priority patent/WO2019116022A1/en
Priority to AU2018381874A priority patent/AU2018381874A1/en
Priority to PCT/GB2018/053590 priority patent/WO2019116021A1/en
Priority to PT188193668T priority patent/PT3585383T/en
Priority to HUE18819365A priority patent/HUE055425T2/en
Priority to AU2018382895A priority patent/AU2018382895A1/en
Priority to PL18819365T priority patent/PL3585382T3/en
Priority to CA3085545A priority patent/CA3085545A1/en
Priority to KR1020207019714A priority patent/KR20200097310A/en
Priority to US15/733,212 priority patent/US11701341B2/en
Priority to ES18819365T priority patent/ES2884789T3/en
Priority to JP2020531621A priority patent/JP7280627B2/en
Priority to DK18819366.8T priority patent/DK3585383T3/en
Ceased legal-status Critical Current

Links

GBGB1720622.8A 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary Ceased GB201720622D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GBGB1720622.8A GB201720622D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
DK18819366.8T DK3585383T3 (en) 2017-12-11 2018-12-11 USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE
EP21156673.2A EP3845228A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
AU2018381874A AU2018381874A1 (en) 2017-12-11 2018-12-11 Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
JP2020531614A JP7372680B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease.
DK18819365.0T DK3585382T3 (en) 2017-12-11 2018-12-11 USE OF 3- [5-AMINO-4- (3-CYANOBENZOYL) -PYRAZOL-1-YL] -N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXTENSIONS OF CHRONIC OBSTRUCTIVE LUNG
ES18819366T ES2882978T3 (en) 2017-12-11 2018-12-11 Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
KR1020207019715A KR20200097311A (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbation of chronic obstructive pulmonary disease
EP18819366.8A EP3585383B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PL18819366T PL3585383T3 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
CA3085544A CA3085544A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
HUE18819366A HUE054266T2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PT188193650T PT3585382T (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
US15/733,213 US11234967B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
PCT/GB2018/053591 WO2019116022A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
EP18819365.0A EP3585382B1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
PCT/GB2018/053590 WO2019116021A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
PT188193668T PT3585383T (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease
HUE18819365A HUE055425T2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
AU2018382895A AU2018382895A1 (en) 2017-12-11 2018-12-11 Use of 3-(5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl)-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
PL18819365T PL3585382T3 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
CA3085545A CA3085545A1 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
KR1020207019714A KR20200097310A (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbation of chronic obstructive pulmonary disease
US15/733,212 US11701341B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
ES18819365T ES2884789T3 (en) 2017-12-11 2018-12-11 Use of 3- [5-amino-4- (3-cyanobenzoyl) -pyrazol-1-yl] -N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
JP2020531621A JP7280627B2 (en) 2017-12-11 2018-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1720622.8A GB201720622D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary

Publications (1)

Publication Number Publication Date
GB201720622D0 true GB201720622D0 (en) 2018-01-24

Family

ID=61007124

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1720622.8A Ceased GB201720622D0 (en) 2017-12-11 2017-12-11 Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary

Country Status (1)

Country Link
GB (1) GB201720622D0 (en)

Similar Documents

Publication Publication Date Title
GB2551295B (en) Autonomous delivery of items
HK1249054A1 (en) Treatment of chronic graft versus host disease with syk inhibitors
ZA201607740B (en) Treatment of the complications of chronic liver disease with caspase inhibitors
IL254142B (en) Tradipitant for use in the treatment of a tradipitant-responsive disease or condition
GB201522870D0 (en) Biometric smartcard with multiple modes of operation
HUE054266T2 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention of acute exacerbations of chronic obstructive pulmonary disease
PL3320901T3 (en) Dimethylaminomicheliolide for use in the treatment of pulmonary fibrosis
IL275349A (en) Use of hm4di in the treatment of seizure disorders
PT3585382T (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease
GB201720622D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary
IL256413B (en) Il-8 inhibitors for use in the treatment of certain urological disorders
PL3405197T3 (en) Use of delgocitinib for the treatment of chronic hand eczema
IL274838A (en) Use of mir101 or mir128 in the treatment of seizure disorders
GB201720624D0 (en) Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the prevention or reduction of acute exacerbations
GB201411150D0 (en) Novel aptamers and therapeutic uses thereof
ZA201902263B (en) Helical impeller
GB2569412B (en) Chlorination of pyrazolinones
GB201700340D0 (en) fluid manipulation cartridge and controller mechanism
GB2559075B (en) Mechatronic drivers in the cold end of a heat pump
HK1217299A1 (en) Mif inhibitors for the acute or chronic treatment of pulmonary hypertension mif
EP3383415A4 (en) Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease
GB201516418D0 (en) Treatment of acute inflammatory disorders
GB201516140D0 (en) Treatment of acute inflammatory disorders
GB201511503D0 (en) Finishing treatment
GB201508711D0 (en) Grip and cue rite

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)